­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hgst/21580/17
    Palliative Gastrectomy Prolongs Survival of Metastatic Gastric Cancer Patients with Normal\nPreoperative CEA or CA19-9 Values: A Retrospective Cohort Study
    01-Jan-1970 Research 2017 : January - March
    Chang-Fang Chiu, Horng-Ren Yang, Mei-Due Yang, Long-Bin Jeng, Tse-Yen Yang, Aaron M Sargeant, Li-Yuan Bai

    Background. Palliative gastrectomy has been suggested to improve survival of patients with metastatic gastric cancer, but limitations\nin study design and availability of robust prognostic factors have cast doubt on the overall merit of this procedure. Methods. The\ncharacteristics and clinical outcomes of 173 patients diagnosed between 2008 and 2012 were analyzed to determine the value of\npalliative gastrectomy and to identify potential prognostic factors. Results. Median overall patient survival was 6.5 months. To\nattenuate potential selection bias, patients with adequate performance and survival time of � 2months since diagnosiswere included\nfor risk factor analysis (

    How to Cite this Article
    CC Compliant Citation: Chang-Fang Chiu, Horng-Ren Yang, Mei-Due\nYang, et al., â??Palliative Gastrectomy Prolongs Survival of Metastatic\nGastric Cancer Patients with Normal Preoperative CEA or CA19-9\nValues: A Retrospective Cohort Study,â? Gastroenterology Research\nand Practice, vol. 2016, Article ID 6846027, 9 pages, 2016.\ndoi:10.1155/2016/6846027, https://creativecommons.org/\nlicenses/by/4.0/.
    Download Full Text